Kate Bingham - Net Worth and Insider Trading

Kate Bingham Net Worth

The estimated net worth of Kate Bingham is at least $43 Million dollars as of 2024-05-28. Kate Bingham is the Director of Bicycle Therapeutics PLC and owns about 1,870,379 shares of Bicycle Therapeutics PLC (BCYC) stock worth over $43 Million. Details can be seen in Kate Bingham's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kate Bingham has not made any transactions after 2021-07-14 and currently still holds the listed stock(s).

Transaction Summary of Kate Bingham

To

Kate Bingham Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kate Bingham owns 1 companies in total, including Bicycle Therapeutics PLC (BCYC) .

Click here to see the complete history of Kate Bingham’s form 4 insider trades.

Insider Ownership Summary of Kate Bingham

Ticker Comapny Transaction Date Type of Owner
BCYC Bicycle Therapeutics PLC 2021-07-14 director

Kate Bingham Latest Holdings Summary

Kate Bingham currently owns a total of 1 stock. Kate Bingham owns 1,870,379 shares of Bicycle Therapeutics PLC (BCYC) as of July 14, 2021, with a value of $43 Million.

Latest Holdings of Kate Bingham

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCYC Bicycle Therapeutics PLC 2021-07-14 1,870,379 23.03 43,074,828

Holding Weightings of Kate Bingham


Kate Bingham Form 4 Trading Tracker

According to the SEC Form 4 filings, Kate Bingham has made a total of 2 transactions in Bicycle Therapeutics PLC (BCYC) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Bicycle Therapeutics PLC is the sale of 44,895 shares on July 14, 2021, which brought Kate Bingham around $2 Million.

Insider Trading History of Kate Bingham

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kate Bingham Trading Performance

GuruFocus tracks the stock performance after each of Kate Bingham's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kate Bingham is -45.11%. GuruFocus also compares Kate Bingham's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kate Bingham within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kate Bingham's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kate Bingham

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -18.08
Relative Return to S&P 500(%) -23.05

Kate Bingham Ownership Network

Ownership Network List of Kate Bingham

No Data

Ownership Network Relation of Kate Bingham


Kate Bingham Owned Company Details

What does Bicycle Therapeutics PLC do?

Who are the key executives at Bicycle Therapeutics PLC?

Kate Bingham is the director of Bicycle Therapeutics PLC. Other key executives at Bicycle Therapeutics PLC include Chief Business Officer Nigel Crockett , Chief Accounting Officer Travis Alvin Thompson , and Chief Operating Officer Alistair Milnes .

Bicycle Therapeutics PLC (BCYC) Insider Trades Summary

Over the past 18 months, Kate Bingham made no insider transaction in Bicycle Therapeutics PLC (BCYC). Other recent insider transactions involving Bicycle Therapeutics PLC (BCYC) include a net sale of 22,315 shares made by Kevin Lee , a net sale of 6,739 shares made by Nigel Crockett , and a net sale of 6,739 shares made by Alistair Milnes .

In summary, during the past 3 months, insiders sold 7,222 shares of Bicycle Therapeutics PLC (BCYC) in total and bought 0 shares, with a net sale of 7,222 shares. During the past 18 months, 53,826 shares of Bicycle Therapeutics PLC (BCYC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,826 shares.

Bicycle Therapeutics PLC (BCYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bicycle Therapeutics PLC Insider Transactions

No Available Data

Kate Bingham Mailing Address

Above is the net worth, insider trading, and ownership report for Kate Bingham. You might contact Kate Bingham via mailing address: 1365 Main Street, Waltham Ma 02451.

Discussions on Kate Bingham

No discussions yet.